News

Cornell researchers have harnessed the power of baker’s yeast to create a cost-effective and highly efficient approach for unraveling how plants synthesize medicinal compounds.

A University team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body’s immune system against the cancer.

Individual species of very different plant families produce special indole-derived defense compounds called benzoxazinoids. However, the biosynthetic pathway of these compounds was so far only known for grasses such as maize.

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but researchers have now discovered a protective genetic mutation.

Cytomegalovirus infection during pregnancy can cause miscarriage and birth defects, but prior exposure to the virus reduces the risk.

What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in health care settings? That’s the premise behind this experimental vaccine.

Imagine a life form that doesn't resemble any of the organisms found on the tree of life. One that has its own unique control system, and that a doctor would want to send into your body.

Researchers have shown the potential of a new gene therapy approach to silence human nerve cells as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.

A new nasal vaccine, which uses an experimental liposome-based approach and is now in Phase 1 clinical trials, could provide long-term protection from Strep A.

A new study from the Norwegian Institute of Public Health (NIPH) found that women who do not menstruate, due to the use of hormonal contraception or menopause, reported unexpected vaginal bleeding after COVID-19 vaccination.